12/22/2014 - 12:42pm

The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.

12/22/2014 - 12:35pm

Prestige lip color sales in the United States experienced a 24% increase in dollar sales during the month of November as the bold lip trend shows little signs of fading, according to global information company, The NPD Group.

12/22/2014 - 12:26pm

Twelve holiday health hazards, provided by Vitals.

 

 

12/22/2014 - 12:12pm

Estée Lauder has signed an agreement to acquire Glamglow, a skin care brand focused on treatment masks. Terms of the deal were not disclosed. The acquisition is expected to close in January 2015.

12/22/2014 - 11:59am

The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.

12/22/2014 - 11:50am

The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.

12/22/2014 - 11:25am

Sandoz has announced the U.S. market introduction of estradiol transdermal system, an authorized generic version of Vivelle-Dot, which is marketed by Novartis Pharmaceuticals.

12/22/2014 - 11:21am

Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.

12/22/2014 - 11:04am

AB Acquisition LLC (Albertsons) and Safeway have entered into agreements to sell 168 stores across eight states to four buyers — Associated Food Stores, Associated Wholesale Grocers, Supervalu and Haggen.